Company profile for Prism Biolab

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

PRISM BioLab, established in 2006, was founded by a group of scientists committed to developing new drugs utilizing their technology of peptide mimetic small molecules. Over more than a decade of research and development, the company has built clinical pipelines and made numerous discoveries of potential seed compounds. Leveraging its PepMetics® Platform, PRISM BioLab has pioneered a proven technology that has successfully ge...
PRISM BioLab, established in 2006, was founded by a group of scientists committed to developing new drugs utilizing their technology of peptide mimetic small molecules. Over more than a decade of research and development, the company has built clinical pipelines and made numerous discoveries of potential seed compounds. Leveraging its PepMetics® Platform, PRISM BioLab has pioneered a proven technology that has successfully generated compounds for targets that were previously considered "undruggable."

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Japan
Address
Address
26-1, Muraoka-Higashi 2-chome, Fujisawa shi, Kanagawa 251-8555
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/prism-biolab-achieved-initial-milestone-and-receives-the-milestone-payment-in-drug-discovery-collaboration-with-ono-pharmaceutical-co-ltd-302615292.html

PR NEWSWIRE
14 Nov 2025

https://www.prnewswire.com/news-releases/eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-asco-american-society-of-clinical-oncology-annual-meeting-302463001.html

PR NEWSWIRE
22 May 2025

https://www.businesswire.com/news/home/20250411890001/en/Elix-and-PRISM-BioLab-Join-Forces-to-Accelerate-AI-Driven-Drug-Discovery-for-Challenging-Protein-Protein-Interaction-Targets

BUSINESSWIRE
15 Apr 2025

https://www.prnewswire.com/news-releases/eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-esmo-european-society-for-medical-oncology-annual-meeting-302241213.html

PR NEWSWIRE
08 Sep 2024

https://www.prnewswire.com/news-releases/prism-biolab-enters-into-a-joint-research-and-licensing-agreement-with-ono-302124401.html

PR NEWSWIRE
25 Apr 2024

https://www.biospectrumasia.com/news/26/23620/japan-based-prism-biolab-raises-1-5-b-to-advance-technologies-for-protein-protein-interactions.html

BIOSPECTRUM ASIA
25 Jan 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty